Functional Fluidics CEO & Founder, Patrick Hines, will be the Scientific Keynote Speaker...

Functional Fluidics CEO & Founder, Patrick Hines, will be the Scientific Keynote Speaker...

0% read

COVID-19 - Sickle Cell Ad Campaign 5X7 with 1_8 Inch bleed3 (2)-1Functional Fluidics CEO & Founder, Patrick Hines, will be the Scientific Keynote Speaker at the 15th Annual Sickle Cell Disease Research & Educational Symposium & 44th National Sickle Cell Disease Scientific Meeting.

The Foundation for Sickle Cell Disease Research’s Upcoming Symposia will attract hundreds of unique individuals from around the world, who are leading researchers, physicians, clinicians, stakeholders, advocates and social workers with the common goal of finding better treatment, and ultimately, a cure for sickle cell disease.

Featured sessions this year are:

1. COVID-19’s Effect on Standard Access to Care, and Now Access to Vaccinations

2. The Life Long Care Costs of Sickle Cell Disease on Caregivers and Individuals, focusing on disability and joblessness

3. The Patient Symposium: “A Tale of Two Pandemics,” focusing on the Sickle Cell Disease crisis that was exacerbated with COVID-19.

4. Updates from the recipients of the Access to Excellent Care for Sickle Cell Disease Grant Program, funded by Global Blood Therapeutics. Recipients are from: Augusta University’s Sickle Cell Transition Program, Atrium Health Foundation, East Carolina University, OSF Healthcare Saint Francis Medical Center, and the University of Rochester Medical Center.

5. The Global Status of Sickle Cell Disease Symposium

6. Real World Experience of Biomarkers and New Therapeutics

7. Trauma-Informed Care, including Socioeconomic Status, Family Trauma, and Health Inequities

8. Post-Transplant Care

9. The Clinical Implications of COVID-19 on Sickle Cell Disease

10. Genomics and Gene Therapy

11. Investigational New Drug, Device and Therapeutics Symposium

12. Top Abstract Presentations, Abstract Breakout Sessions and an all-day Poster Session

 

Register

Subscribe to our Newsletter